Earnings · China A-shares
North China Pharmaceutical Company Ltd. Class A (600812) earnings
North China Pharmaceutical Company Ltd. Class A published its Q3 report on 2026-10-27: net profit -59.06% year on year, -72.52% excluding one-off items. Wave Radar's earnings-quality score is 95 of 100 (Sound). The stock moved -3.19% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-27
- Period end
- 2026-09-30
- Net profit YoY
- -59.06%
- Excl. one-offs YoY
- -72.52%
- Net profit QoQ
- -96.31%
- Result
- Bad / loss
- Quality score
- 95
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +0.00% | — |
| 3 days | -3.19% | — |
| 7 days | +3.40% | — |
| 14 days | -1.28% | — |
Report history
Over the last 8 reports, net profit grew year on year in 5 of them. The stock rose in the 3 trading days after 0 of 8 reports (average -2.21%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-28 | ¥64.89M | -59.06% | -72.52% | -19.71% | 0.04 | 1.17% | -3.19% | — | — |
| 2026 interim report | 2026-08-22 | ¥63.85M | -48.30% | -51.16% | -20.01% | 0.04 | 1.15% | -0.41% | +35.03% | +41.95% |
| 2026 Q1 report | 2026-04-25 | ¥35.47M | -38.30% | -41.57% | -16.36% | 0.02 | 0.64% | -0.94% | -17.48% | -17.18% |
| 2025 annual report | 2026-04-18 | ¥183.06M | +44.15% | +46.99% | -6.36% | 0.11 | 3.36% | -1.82% | -18.40% | -23.16% |
| 2025 Q3 report | 2025-10-25 | ¥158.50M | +54.69% | +73.61% | -1.00% | 0.09 | 2.90% | -0.82% | -3.78% | -3.56% |
| 2025 interim report | 2025-08-14 | ¥123.50M | +71.56% | +120.69% | +0.84% | 0.07 | 2.27% | -4.35% | -15.65% | -25.00% |
| 2025 Q1 report | 2025-04-24 | ¥57.49M | +216.72% | +376.62% | +0.65% | 0.03 | 1.06% | -2.50% | +4.33% | +2.06% |
| 2024 annual report | 2025-03-28 | ¥126.99M | +2496.80% | +349.55% | -2.48% | 0.07 | 2.38% | -3.65% | -9.57% | -8.48% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
Stock valuations: 600812 · Stock news: 600812
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.